Mimic human complexity in a beat!
OUR MISSION
At BiomimX® we develop reliable, predictive and fast responsive human pre-clinical solutions to support drug and medical device development.
Integrating 3D cell culture and mechanical stimulation, BiomimX® proposes the next generation of beating organs-on-chips, allowing to recapitulate human organs’ function and human diseased states with an unprecedented level of precision.
OUR VISION
BiomimX® is a technology driven company projected towards the development of innovative and 3R compliant preclinical solutions that will revolutionize the standards for testing drug and medical devices.
BUSINESS AREAS
DRUG DISCOVERY AND SAFETY
BiomimX® provides advanced human in vitro models to detect drug efficacy and adverse effects, representing a more clinically relevant alternative to existing models.
MEDICAL DEVICE ASSESSMENT
In line with the new EU Medical Device Regulation (MDR (EU)2017/745), BiomimX® offers advanced preclinical models to test medical device efficacy before undergoing clinical trials.
PRECISION MEDICINE
Future developments include envisioned precision medicine approaches, where candidate compounds and therapies are screened on disease- and, ultimately, patient-specific models.
Are you interested in applying for the prestigious Marie Curie Individual Fellowship #H20200 #MSCA-IF in the Society & Enterprise panel?
Applying with BiomimX® Srl as host institution will give you the opportunity to work with a dynamic and fast growing SME leader in the field of Organs on Chip!